top of page
  • Patient Education

Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj - Monoclonal Ab - Immunotherapy

Updated: Jan 27

  • Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj

Daratumumab

DARATUMUMAB (DARZALEX)


NIH National cancer institute - cancer.gov site info

This page contains brief information about daratumumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Darzalex

FDA Approved: Yes

 

MedlinePlus Information

A lay language summary of important information about this drug that may include the following:

warnings about this drug,

what this drug is used for and how it is used,

what you should tell your doctor before using this drug,

what you should know about this drug before using it,

other drugs that may interact with this drug, and

possible side effects.

 

Information on Darzalex website




DARATUMUMAB AND HYALURONIDASE-FIHJ (DARZALEX FASPRO)



NIH National cancer institute - cancer.gov site info

This page contains brief information and collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Darzalex Faspro

FDA Approved: Yes

 

MedlinePlus Information

A lay language summary of important information about this drug that may include the following:

warnings about this drug,

what this drug is used for and how it is used,

what you should tell your doctor before using this drug,

what you should know about this drug before using it,

other drugs that may interact with this drug, and

possible side effects.

 

INTERNATIONAL MYELOMA FOUNDATION:


Understanding DARZALEX and DARZALEX FASPRO


IMF Understanding Series


IMF Resource Library


Current FDA-Approved Medications for Multiple Myeloma Treatment

 

HEALTH TREE UNIVERSITY MYELOMA:


All About Darzalex (daratumumab)


HealthTree University for Multiple Myeloma Lectures


HealthTree University Myeloma Videos

 

MULTIPLE MYELOMA RESERACH FOUNDATION:


Standard Treatments - Darzalex/Darzalex Faspro


MMRF Education Programs


MMRF Videos

 

References DARZALEX & DARZALEX FASPRO:


FDA Label Prescribing Information (Revised 03/2022)


FDA Label Prescribing Information (Revised 01/2022)


Drug Label Information at DAILYMED - NIH-National Library of Medicine



Other Resources

 

- Multiple Myeloma Patient Education & Information on ongoing Multiple Myeloma Clinical Trials -

* Belantamab mafodotin (Withdrawn from United States market)


Posts Archive
bottom of page